View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19.
Content based on a CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/conference-coverage/covid19-2020
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois
Senior Scientific Director
Executive Vice President
This program has been made available online.
Watch this presentation by Professor David Heymann discussing the concept of herd immunity and considerations for estimating the herd immunity threshold for SARS-CoV-2
David Heymann, BA, MD, DTM&H
Released: September 18, 2020
Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment
Adaora A. Adimora, MD, MPH
David Heymann, BA, MD, DTM&H
Sharon R. Lewin, AO, FRACP, FAHMS
Jens D. Lundgren, MD, DMSc
Vikramjit Mukherjee, MD
Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS
Released: September 14, 2020
Presentation by Professor Jens D. Lundgren discussing the current evidence and recommendations regarding the use of convalescent plasma to treat COVID-19 from CCO
Jens D. Lundgren, MD, DMSc
Released: September 11, 2020
Watch this concise presentation by Professor Sharon Lewin on durability of antibody and T cell responses to SARS-CoV-2 and the current understanding of reinfection
Sharon R. Lewin, AO, FRACP, FAHMS
Released: September 4, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.